Start Over

Immunomodulatory effects of Calcitriol in acute spinal cord injury in rats.

Authors :: Khajoueinejad L
Askarifirouzjaei H
Namazi F
Mohammadi A
Pourfathollah AA
Rajaian H
Fazeli M
Source :: International immunopharmacology [Int Immunopharmacol] 2019 Sep; Vol. 74, pp. 105726. Date of Electronic Publication: 2019 Jul 02.
Publication Year :: 2019
Abstract: Pharmacological therapy options for spinal cord injury (SCI) in acute phase have so far been limited, thus we focused on Calcitriol, FDA-approved biologically active form of vitamin D whose neuroprotective effects are increasingly recognized, to ameliorating damage following acute SCI in rats. Calcitriol (1 μg/kg) treatment for 7 consecutive days after SCI was compared SCI control and Sham control rat groups. Calcitriol-treated group had significantly improved outcome in standard functional recovery evaluation test (BBB) 12 weeks after SCI compared to SCI control, which was confirmed by increased ventral horn motor neurons in Calcitriol-treated group. In addition, proliferation test performed on lymphocytes from spleen and lymph nodes one week after SCI showed that calcitriol injection has a significant regulatory effect on Division Index (DI) in response to MBP stimulation compared to control SCI groups, which was associated with significant reduction in IFN-γ and IL-17A secretion and leukocyte infiltration into injury site. Along with confirmation of immunoregulatory aspects of Calcitriol treatment against myelin antigens in SCI, this study has shown that reducing the extent of progressive tissue loss by Calcitriol therapy in acute phase, could result in better recovery after SCI.<br /> (Copyright © 2019 Elsevier B.V. All rights reserved.)